Related Experiment Video
Updated: Feb 22, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Inflammatory biomarkers of coronary heart disease
Hongyu Li1, Kai Sun2, Ruiping Zhao3
1Department of Cardiology, Baotou Central Hospital, Baotou, China.
Insights
Coronary heart disease (CHD) involves arterial plaque buildup, leading to angina and heart attacks. Inflammatory biomarkers like C-reactive protein (CRP) help assess CHD severity and prognosis.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Pathophysiology
Background:
- Coronary heart disease (CHD) is a major global cause of mortality.
- Pathologically, CHD involves arterial plaque formation (lipids, calcium, inflammatory cells) narrowing coronary arteries.
- Plaque rupture can cause thrombus formation, leading to myocardial infarction and death, often exacerbated by risk factors like obesity, diabetes, and hypertension.
Purpose of the Study:
- To highlight the role of inflammation in CHD pathogenesis.
- To underscore the diagnostic and prognostic significance of inflammatory biomarkers in CHD.
Main Methods:
- Diagnosis of CHD relies on assessing blood lipid profiles (cholesterol, triglycerides, lipoproteins).
- Assessment of CHD severity and prognosis involves measuring inflammatory biomarkers.
- Key inflammatory biomarkers include interleukin-6, C-reactive protein (CRP), complement, CD40, and myeloperoxidase (MPO).
Main Results:
- Inflammation is a significant factor in the development and progression of CHD.
- Elevated levels of specific inflammatory biomarkers correlate with CHD severity and prognosis.
Conclusions:
- Understanding the inflammatory component of CHD is crucial for effective management.
- Monitoring inflammatory biomarkers offers valuable insights into patient outcomes for coronary heart disease.
Abstract:
Coronary heart disease (CHD) is one of the leading causes of death worldwide. CHD is characterized by formation of arterial plaques which are mainly comprised of lipids, calcium and inflammatory cells. These plaques narrow the lumen of coronary arteries leading to episodic or persistent angina. Rupture of these plaques leads to the formation of thrombus, which as a result of cessation of blood flow, causes myocardial infarct and death. CHD is exacerbated by risk factors including obesity, diabetes mellitus, and hypertension. Diagnosis is established by the level of blood cholesterol, triglycerides and lipoproteins Inflammation is considered significant in the pathogenesis of CHD and for this reason, severity and prognosis of CHD is assessed by the levels of inflammatory biomarkers, including interleukin-6, C-reactive protein (CRP), complement, CD40 and myeloperoxidase (MPO).
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology